{"prompt": "['Amended Clinical Trial Protocol 03', '18-Oct-2019', 'EFC14153 - dupilumab', 'Version number: 1', 'Property of the Sanofi Group - strictly confidential', 'Page 146', 'VV-CLIN-0528583 6.0']['Amended Clinical Trial Protocol 03', '18-Oct-2019', 'EFC14153 - dupilumab', 'Version number: 1', 'Appendix G', 'Paediatric Asthma Quality of Life Questionnaire With Standardised', 'Activities-Interviewer Administered (PAQLQ[S]-IA)', 'C', 'The Paediatric Asthma Quality of Life Questionnaire with Standardised', 'Activities (PAQLQ(S)) is copyrighted and all rights are reserved. No part of', 'this questionnaire may be sold, modified or reproduced in any form', 'without the express permission of Elizabeth Juniper on behalf of QOL', 'Technologies Limited', 'JANUARY 2001', 'Revised 08 December 2010', 'PAQLQ(S)-IA - North American English Version', 'Property of the Sanofi Group - strictly confidential', 'Page 147', 'VV-CLIN-0528583 6.0']['Amended Clinical Trial Protocol 03', '18-Oct-2019', 'EFC14153 - dupilumab', 'Version number: 1', 'Property of the Sanofi Group - strictly confidential', 'Page 148', 'VV-CLIN-0528583 6.0']\n\n###\n\n", "completion": "END"}